Indications of denosumab | No. of institutions (%) |
---|---|
Unresectable | 21 (88%) |
Difficult to joint preservation | 17 (71%) |
Expanding to soft tissue | 11 (46%) |
Adjusting the time of operation | 7 (29%) |
Perioperative use with curettage | 6 (25%) |
No experience of denosumab use | 3 (13%) |